- 新冠病毒SARS-CoV-2传播力:高传染性和高隐蔽性 (0篇回复)
- 流感疫苗或重回三价时代 (0篇回复)
- 中国流感流行情况概要(截至2023年10月15日) (0篇回复)
- AAV基因治疗产品临床试验申请药学研究与评价技术指导原则 (0篇回复)
- 李靖|姜涛等利用深度学习预测奥密克戎等新冠变异病毒对... (1篇回复)
- 孙兵与丛尧组合作发现一种独特的流感病毒广谱中和抗体... (0篇回复)
- 灭活疫苗对新冠变异病毒的中和效果 (2篇回复)
- 人内源性逆转录病毒HERV与慢性疲劳综合征CFS (3篇回复)
- 冬季莅临,防范意识从我做起,用自己的知识尽一份绵薄之力-B I H I (2篇回复)
- 小分子ACA靶向TGF-β信号通路可抑制包括新冠病毒 (1篇回复)
- 【文献阅读】新型限制性因子慢病毒递送载体应对HIV感染 (1篇回复)
- 【前沿速递】余宏杰课题组在引起手足口病的肠道病毒基... (2篇回复)
- 港大专家: 二次感染新冠病毒患者病情较轻微 (0篇回复)
- 中国团队发现可阻断新冠病毒感染的人源单克隆抗体 (1篇回复)
- The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice (0篇回复)
- HIV腺病毒改造思路 (0篇回复)
- Integrative functional genomics decodes herpes simplex virus 1 (0篇回复)
- 《自然》发表武汉大学蓝柯教授团队新冠病毒气溶胶研究... (0篇回复)
- 【前沿速递】无症状者具有传染性!!!| 新冠肺炎住院病人的病毒学特性详析。 (1篇回复)
- 复旦大学陆路/姜世勃等发现新的冠状病毒抑制剂,有望快... (1篇回复)
- 重磅!揭示病毒起源,为药物与疫苗研发提供有力支持! (1篇回复)
- 武汉大学钟波课题组揭示USP22调控天然免疫应答机制 (2篇回复)
- 病毒学论坛沉痛悼念李文亮医生,一路好走! (0篇回复)
- 2019-nCoV最新文献实时更新 (4篇回复)
- JVI|天津大学王涛课题组研究发现应激颗粒抑制人肠道病毒D68复制机制 (0篇回复)
- Low-Fidelity Assembly of Influenza A Virus Promotes Escape from Host Cells (0篇回复)
- 病毒的使用 (0篇回复)
- Neuraminidase Is an Important Target for Influenza Vaccination (1篇回复)
- Integrated Pan-Cancer Map of EBV-Associated Neoplasms (0篇回复)
- 病毒学国家重点实验室蓝柯研究组揭示卡波氏肉瘤病毒(KS... (0篇回复)
- Measles erases immune ‘memory’ for other diseases (0篇回复)
- Simplified steps to heterologous prime-boost HIV vaccine development? (0篇回复)
- broadly neutralizing antibodies associated with hepatitis C virus clearance (0篇回复)
- Segmented Filamentous Bacteria Prevent and Cure Rotavirus Infection (1篇回复)
- The Human Gut Virome Is Highly Diverse, Stable, and Individual Specific (0篇回复)
- Hepatitis D Virus Infection Revisited (0篇回复)
- Zika Virus NS3 Mimics a Cellular 14-3-3-Binding Motif to Antagonize Innate Im... (0篇回复)
- 八种人类疱疹病毒简介 (0篇回复)
- 艾伯维Mavyret8周方案获批,治疗初治伴代偿性肝硬化患者! (0篇回复)
- FHL1 is a major host factor for chikungunya virus infection (0篇回复)